Literature DB >> 16340902

[Uterine factors limiting ART coverage].

P Piver1.   

Abstract

Transvaginal sonographic evaluation of endometrial texture and thickness may be an indicator of the likelihood of achieving pregnancy. Very few pregnancies occur when the endometrial thickness was less than 6 mm. When type C endometrium (multilayered endometrium consisting of prominent outer and midline hyperechogenic lines and inner hypoechogenic regions) greater than or equal to 6 mm thick was seen, the pregnancy rate per embryo transfer is goods. MR imaging is highly accurate in helping to diagnose adenomyosis which is a cause of repeated implantation failures in women undergoing IVF. Furthermore the MRI evaluation of junctional zone thickness (AJZ>7 mm and MJZ>10 mm) is the best negative predictive factor of implantation failure (97%). Thus, we advocate the measurement of junctional zone thickness with MRI in women with 2 consecutive implantation failure following IVF.

Entities:  

Mesh:

Year:  2005        PMID: 16340902

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  4 in total

1.  Infertility and adenomyosis.

Authors:  Sebastiano Campo; Vincenzo Campo; Giuseppe Benagiano
Journal:  Obstet Gynecol Int       Date:  2011-12-26

Review 2.  The Impact of Adenomyosis on Women's Fertility.

Authors:  Tasuku Harada; Yin Mon Khine; Apostolos Kaponis; Theocharis Nikellis; George Decavalas; Fuminori Taniguchi
Journal:  Obstet Gynecol Surv       Date:  2016-09       Impact factor: 2.347

3.  A rare case of extensive placenta accreta in twin pregnancy after GnRH agonist treatment of adenomyosis.

Authors:  Shilpi Agrawala; Jeevitha Patil; Sukhkamal Campbell; Terri Lynn Woodard
Journal:  Fertil Res Pract       Date:  2021-03-03

4.  Decreased intracellular IL-33 impairs endometrial receptivity in women with adenomyosis.

Authors:  Bin He; Xiao-Ming Teng; Fan Hao; Mei Zhao; Zhi-Qin Chen; Kun-Ming Li; Qiang Yan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.